Denbright Dental Labs has appointed David Casper as its CEO.
Casper is an experienced global executive with over 30 years of experience in the dental and medical device industries. Most recently, he served as CEO of DenMat Holdings (2017-2023), a global business which includes a professional dental products portfolio as well as a dental laboratory focused on cosmetic restorations, which he successfully transacted to a strategic buyer. Previously, he served as president of the medical device division of Glidewell Laboratories, where he was responsible for all of the division’s functions including product strategy, operations, and M&A. During his time at Glidewell, he also served as vice-president of business development. Prior to Glidewell, Casper ran the dental implant platform for Danaher Corporation’s dental division as managing director. Through these experiences, David has executed on transformative growth strategies both organically and through M&A. He has also held executive leadership roles at companies such as General Electric and Nobel Biocare.
“I am thrilled to become part of a differentiated dental lab platform who has proven to be an industry leader,” Casper commented. “Denbright’s business model uniquely focuses on being a full solutions partner through offering its customers support in digital workflow/technology adoption and clinical education, in addition to being a full-service lab offering high quality prosthetics across all product categories. I look forward to partnering with our best-in-class management team and lab operators to accelerate growth for our valued employees and customers.”
Jimmy Frye at O2 Investment Partners commented: “We couldn’t be more excited for David to join Denbright’s management team. He has an impressive track record of leading and scaling businesses in the dental industry, and adds a tremendous amount of expertise and firepower to our team as we continue to execute our strategic initiatives. His addition further bolsters Denbright as one of the most scaled and sophisticated dental labs in the country.”
Denbright has further strengthened its management team through the appointments of Conrad Rensburg to president, John Ballard to COO, and Sid Jain as chief integration officer.
